CRVLCorVel Corporation
Is the price fair?
In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In its normal range: P/E 34.3 vs a 38.0 median over 41 quarters (−10% vs median).
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.
What CRVL's price assumes
CorVel Corporation trades at 34.3× earnings against 27.9× for the median Insurance Brokers name, more expensive than its own group.
Trailing P/E · Insurance Brokers median 27.9 · 1.23× the median: the market pays up for this one
- Price / sales
- 3.20
Price / sales · as of 2026-Q2
- Price / book
- 7.69
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 7.69
- Financial Services median P/E625 names
- 12.1
- Insurance Brokers median P/E15 names
- 27.9
- Market capitalisation
- $3.13B
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $64.82 |
| Its own P/E history, median | $85.43 |
| Its own P/E history, upper quartile | $109.67 |
| 52-week range | $46.00 – $80.11 |
| Today | $77.17 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.